Dr. Jason E. Tache, DO

Dr. Tache practices at South Florida Oncology and Hematology Consultants in Plantation, Florida.

Dr. Tache's NPI, 1679561294, was assigned on October 7, 2005. Dr. Tache graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1999. Dr. Tache holds Florida license OS8847.

Dr. Tache's primary practice is South Florida Oncology and Hematology Consultants, at 260 SW 84th Ave, Plantation, FL 33324 in Broward County. The practice phone is (954) 749-6951.

Dr. Tache's primary practice is South Florida Oncology and Hematology Consultants in Plantation, Florida. Dr. Tache is also affiliated with HCA Florida Westside Hospital. The medical group on file is South Florida Oncology and Hematology Consultants. Dmand AI also links Dr. Tache to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tache practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tache's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tache is board certified in hematology by the American Board of Internal Medicine. Dr. Tache is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Tache treats.

CMS data shows 51,711 Medicare services from Dr. Tache across 20 procedure codes in 2024, for 348 Medicare patients. Medicare paid $303,852 for them.

CMS counts 348 Medicare patients who saw Dr. Tache in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tache's median patient age at 70, with 60% women.

In 2024, Dr. Tache wrote 2,245 Medicare Part D claims for 331 patients. 60% of them were for generic drugs. CMS names the drug for 1,866 of them, across 56 drugs with 11 or more claims each, at $5,955,267 in total drug cost. In 2023, CMS named 1,807 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tache for performance year 2024, reported individually. Dr. Tache accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Tache in 2017. Dr. Tache's most frequent co-authors are Tina Ataian Binazir, MD, Harry Marshak, MD and Sameer Shaharyar, MD.

Dmand AI links Dr. Tache to 11 clinical trials, 6 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell and Brain Neoplasms. Karyopharm Therapeutics Inc sponsors the most, 2. Open Payments lists research payments to Dr. Tache that name 1 trial.

CMS Open Payments shows 1,104 general payments to Dr. Tache from 63 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 32% of the total. Celgene Corporation paid the most, $21,599. It also lists 1 research payment totaling $1,238 in 2023, naming 1 clinical trial.

Dr. Tache graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1999. Dr. Tache is a member of AOA.

Dr. Tache is in network with 17 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.